Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 49 citing Sasso: Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic.... (0.08 sec) 

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes


CE Mogensen - Journal of internal medicine, 2003 - ingentaconnect.com
Over the past decade, there has been considerable focus on the concept of
microalbuminuria, not only because it predicts renal disease in type 1 and type 2 diabetes, but
also because it relates to premature mortality in the diabetic and in the general ...
Cited by 145 - Related articles - BL Direct - All 7 versions

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the …

- annals.org
R Kunz, C Friedrich, M Wolbers, JFE … - Annals of Internal …, 2007 - Am Coll Physicians
This position paper concerns improving health care in the United States. Unlike previous highly
focused policy papers by the American College of Physicians, this article takes a comprehensive
approach to improving access, quality, and efficiency of care. The first part describes ...
Cited by 120 - Related articles - BL Direct - All 6 versions

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial …

- ahajournals.org
A Ceriello, R Assaloni, R Da Ros, A Maier, L Piconi, L … - Circulation, 2005 - Am Heart Assoc
Methods and Results— Twenty type 2 diabetic patients ate 3 different test meals: a high-fat
meal, 75 g glucose alone, and a high-fat meal plus glucose. Glycemia, triglyceridemia, endothelial
function, nitrotyrosine, C-reactive protein, intercellular adhesion molecule-1, and ...
Cited by 103 - Related articles - All 10 versions

Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy …

- critcaremed.com
M Burnier, A Zanchi - Journal of hypertension, 2006 - journals.lww.com
Diabetes (particularly type 2 diabetes) represents a global health problem of epidemic
proportions. Individuals with diabetes are not only more likely to develop hypertension,
dyslipidemia, and obesity, but are also at a significantly higher risk for coronary heart ...
Cited by 60 - Related articles - BL Direct - All 8 versions

Irbesartan: a review of its use in hypertension and in the management of diabetic …

- adisonline.com [PDF] 
KF Croom, MP Curran, KL Goa, CM Perry - Drugs, 2004 - ingentaconnect.com
0012-6667/04/0009-0999/$34.00/0  2004 Adis Data Information BV. All rights reserved. ...
A Review of its Use in Hypertension and in the Management of Diabetic Nephropathy ... Katherine
F. Croom, Monique P. Curran, Karen L. Goa and Caroline M. Perry
Cited by 49 - Related articles - BL Direct - All 6 versions

[CITATION] Diabetic renal disease: from recent studies to improved clinical practice


CE Mogensen, ME Cooper - Diabetic Medicine, 2004 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 40 - Related articles - BL Direct - All 4 versions

Hypertension and microalbuminuria: the new detrimental duo


P Verdecchia, GP Reboldi - Blood pressure, 2004 - informahealthcare.com
INTRODUCTION The standard urine protein dipstick becomes positive for overt proteinuria when
urinary albumin excretion (UAE) exceeds 300 mg per day, or 200 mg/min. However, the normal
rate of albumin excretion in urine is considerably less, in the order of <20 mg/day, or <15 ...
Cited by 22 - Related articles - BL Direct - All 6 versions

Preserving cardiac function in the hypertensive patient: why renal parameters hold …

- oxfordjournals.org
G Montalescot, JP Collet - European heart journal, 2005 - Eur Soc Cardiology
The relationship between cardiovascular and renal pathologies is well recognized in advanced
nephropathy and heart failure, but in early disease it has received less attention.
Consequently, microalbuminuria screening and interventions that treat early nephropathy ...
Cited by 21 - Related articles - BL Direct - All 5 versions

The renal protective effects of angiotensin II receptor blockers in type 2 diabetes …


JD Coyle, SF Gardner, CM White - The Annals of …, 2004 - Harvey Whitney Books
Published Online, 7 September 2004, www.theannals.com, DOI 10.1345/aph.1E182. The Annals
of Pharmacotherapy: Vol. 38, No. 10, pp. 1731-1738. DOI 10.1345/aph.1E182 © 2004 Harvey
Whitney Books Company. ... OBJECTIVE: To review the renal protective effects of ...
Cited by 20 - Related articles - BL Direct - All 4 versions

Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with …

- nih.gov [PDF] 
EO Ofili, KC Ferdinand, E Saunders, JM … - Journal of the …, 2006 - pubmedcentral.nih.gov
Financial support: The clinical study considered by this publi- cation was sponsored by the
Bristol-Myers Squibb Sanofi-Syn- thelabo Partnership. The sponsor provided funding and
in-kind support for the clinical trial and for the publication. The sponsor, the Bristol-Myers ...
Cited by 16 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google